ANI Pharmaceuticals, Inc. (ANIP)
ANIP Stock Price Chart
Explore ANI Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ANIP price movements and trends.
ANIP Company Profile
Discover essential business fundamentals and corporate details for ANI Pharmaceuticals, Inc. (ANIP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
5 May 2000
Employees
970.00
CEO
Nikhil Lalwani
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANIP Financial Timeline
Browse a chronological timeline of ANI Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 14 Aug 2026
EPS estimate is $2.01, while revenue estimate is $260.84m.
Earnings released on 8 May 2026
EPS came in at $2.05 surpassing the estimated $1.28 by +60.16%, while revenue for the quarter reached $237.46m , beating expectations by +14.37%.
Earnings released on 27 Feb 2026
EPS came in at $2.33 surpassing the estimated $1.99 by +17.09%, while revenue for the quarter reached $247.06m , beating expectations by +6.91%.
Earnings released on 7 Nov 2025
EPS came in at $2.04 surpassing the estimated $1.74 by +17.24%, while revenue for the quarter reached $227.81m , missing expectations by -1.91%.
Earnings released on 8 Aug 2025
EPS came in at $1.80 surpassing the estimated $1.38 by +30.43%, while revenue for the quarter reached $211.37m , beating expectations by +1.23%.
Earnings released on 9 May 2025
EPS came in at $1.70 surpassing the estimated $1.37 by +24.09%, while revenue for the quarter reached $197.12m , beating expectations by +4.44%.
Earnings released on 28 Feb 2025
EPS came in at $1.63 surpassing the estimated $1.41 by +15.60%, while revenue for the quarter reached $190.57m , beating expectations by +12.13%.
Earnings released on 8 Nov 2024
EPS came in at $1.34 surpassing the estimated $1.09 by +22.94%, while revenue for the quarter reached $148.33m , missing expectations by -15.30%.
Earnings released on 6 Aug 2024
EPS came in at $1.02 surpassing the estimated $0.93 by +9.68%, while revenue for the quarter reached $138.04m , beating expectations by +6.97%.
Earnings released on 10 May 2024
EPS came in at $1.21 surpassing the estimated $0.98 by +23.47%, while revenue for the quarter reached $137.43m , beating expectations by +9.49%.
Earnings released on 29 Feb 2024
EPS came in at $1.00 surpassing the estimated $0.80 by +25.00%, while revenue for the quarter reached $131.65m , beating expectations by +7.73%.
Earnings released on 8 Nov 2023
EPS came in at $1.27 surpassing the estimated $0.76 by +67.11%, while revenue for the quarter reached $131.83m , beating expectations by +7.84%.
Earnings released on 9 Aug 2023
EPS came in at $1.28 surpassing the estimated $0.64 by +100.00%, while revenue for the quarter reached $116.55m , beating expectations by +18.08%.
Earnings released on 8 May 2023
EPS came in at $1.17 surpassing the estimated $0.34 by +244.12%, while revenue for the quarter reached $106.79m , beating expectations by +27.90%.
Earnings released on 9 Mar 2023
EPS came in at $0.76 surpassing the estimated $0.68 by +11.76%, while revenue for the quarter reached $94.23m , beating expectations by +9.39%.
Earnings released on 9 Nov 2022
EPS came in at $0.64 surpassing the estimated $0.58 by +10.34%, while revenue for the quarter reached $83.82m , beating expectations by +6.97%.
Earnings released on 8 Aug 2022
EPS came in at $0.13 surpassing the estimated $0.12 by +8.33%, while revenue for the quarter reached $73.86m , beating expectations by +2.62%.
Earnings released on 10 May 2022
EPS came in at -$0.12 falling short of the estimated $0.08 by -250.00%, while revenue for the quarter reached $64.48m , missing expectations by -0.86%.
Earnings released on 15 Mar 2022
EPS came in at $0.54 falling short of the estimated $0.82 by -34.15%, while revenue for the quarter reached $60.93m , beating expectations by +8.22%.
Earnings released on 1 Nov 2021
EPS came in at $1.01 surpassing the estimated $0.71 by +42.25%, while revenue for the quarter reached $52.06m , beating expectations by +4.75%.
Earnings released on 6 Aug 2021
EPS came in at $0.67 surpassing the estimated $0.65 by +3.08%, while revenue for the quarter reached $48.63m , beating expectations by +1.20%.
ANIP Stock Performance
Access detailed ANIP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
